How to Transition to Basal Insulin and Determine Daily Dose
Initial Basal Insulin Dosing
Start basal insulin at 10 units per day OR 0.1-0.2 units/kg per day for insulin-naïve patients with type 2 diabetes. 1
- For a 70 kg patient, this translates to 7-14 units daily 1
- Choose between basal analog insulins (glargine, detemir, degludec) or bedtime NPH insulin based on cost and patient-specific factors 1
- Prescribe glucagon for emergent hypoglycemia when initiating insulin 1
Setting Target and Titration Strategy
Establish a fasting plasma glucose (FPG) goal before beginning titration—typically 80-130 mg/dL for most adults. 1
Evidence-Based Titration Algorithm:
- Increase dose by 2 units every 3 days until FPG goal is reached without hypoglycemia 1
- Alternative approach: increase by 1 unit per day for NPH, detemir, and glargine U-100, or 2-4 units once or twice weekly for all basal insulins 2
- Assess adequacy of insulin dose at every visit 1
Hypoglycemia Management During Titration:
- If hypoglycemia occurs, determine the cause 1
- If no clear reason identified, reduce dose by 10-20% 1
- Document all hypoglycemic episodes (blood glucose <70 mg/dL) and adjust the treatment plan 1
Monitoring for Overbasalization
Watch for clinical signals indicating overbasalization rather than continuing to escalate doses indefinitely. 1
Key warning signs include:
- Elevated bedtime-to-morning glucose differential 1
- Elevated postprandial-to-preprandial glucose differential 1
- Hypoglycemia (aware or unaware) 1
- High glucose variability 1
When these occur, consider adding adjunctive therapies (GLP-1 RA, prandial insulin) rather than further increasing basal insulin 1
Special Considerations for Specific Basal Insulins
NPH Insulin:
- Administer at bedtime for most patients 1
- Consider morning dosing for steroid-induced hyperglycemia 1
- Higher risk of hypoglycemia compared to analogs 1
Long-Acting Analogs (Glargine, Detemir, Degludec):
- Glargine U-100/U-300 and degludec: typically once daily 3
- Detemir: may require twice-daily dosing for effective control 4
- When switching from glargine U-100 to U-300, expect to need higher doses (median increase from 30 to 34.5 units) 5
- When switching from glargine U-100 to degludec, doses typically remain similar 5
Transitioning from Other Insulin Regimens
From IV to Subcutaneous Insulin (Hospital Setting):
Administer subcutaneous basal insulin 2 hours before discontinuing IV insulin infusion to prevent rebound hyperglycemia. 1
- Calculate total daily dose based on insulin infusion rate during prior 6-8 hours when stable glycemic goals were achieved 1
- Alternative: use prior home insulin dose or weight-based approach (0.1-0.2 units/kg) 1
- Consider adding low-dose basal analog (0.15-0.3 units/kg) during IV infusion to reduce duration and prevent rebound 1
From Other Basal Insulins:
- Unit-to-unit conversion is appropriate when switching between most basal insulins 1
- Consider 20% dose reduction when transitioning to prevent hypoglycemia, particularly in elderly or renally impaired patients 6
- For patients requiring higher doses (≥0.6 units/kg/day), approximately 50-60% should be basal insulin, 40-50% prandial 6
Common Pitfalls to Avoid
- Never use sliding scale insulin alone without basal coverage—this leads to poor glycemic control 1, 3
- Avoid therapeutic inertia: reassess and modify insulin doses regularly every 3-6 months 1
- Do not continue escalating basal insulin beyond approximately 0.5-1.0 units/kg/day without reassessing the regimen 2
- For patients with renal insufficiency, start with lower doses (0.1 units/kg/day) and titrate cautiously 1, 6
- Ensure proper injection technique and site rotation within the same region (thigh, abdomen, upper arm) 4
When to Add Prandial Insulin
If A1C remains above goal despite optimized basal insulin:
- Start with 4 units per dose, 0.1 units/kg, or 10% of basal insulin dose at the largest meal or meal with greatest postprandial glucose excursion 1, 7
- If A1C <8%, consider reducing basal dose by 4 units or 10% when adding prandial insulin to prevent hypoglycemia 1, 7
- Progress to full basal-bolus regimen (approximately 50% basal, 50% prandial) if needed 7, 3